foxo4-dri senolytic 2024 induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation Mechanisms of action of senolytic
Description
Specifically, a peptide known as Body Protection Compound 157 or BPC 157 has been touted to accelerate tissue healing
Ongoing phase 3 trials are in progress, and CagriSema is currently under FDA review, with a decision expected in late 2026
Excessive ECM combined with inadequate remodeling of scar tissue results in an aesthetically and functionally unsatisfactory, painful, pruritic scar that can impair function
Explored in restorative biological process studies
The Epitalon tetrapeptide restrained the HG-induced gene expression of SNAIL-1 in a concentration-dependent manner (Fig
